logo

For the Inventor, By the Inventor

Palo Alto, CA, United States of America

James W Young

USPTO Granted Patents = 50

 

Average Co-Inventor Count = 1.5

ph-index = 17

Forward Citations = 645(Granted Patents)

Forward Citations (Not Self Cited) = 617(Dec 10, 2025)


Location History:

  • Grand Prairie, TX (US) (1983 - 1988)
  • Still River, MA (US) (1992 - 2000)
  • Palo Alto, CA (US) (1979 - 2004)

Company Filing History:

goldMedal47 out of 322 
 
Sepracor, Inc.
 patents
silverMedal1 out of 484 
 
Georgetown University
 patents
bronzeMedal1 out of 2,202 
 
The United States of America As Represented by the Secretary of
 patents
4. 1 out of 123 
 
The Mclean Hospital Corporation
 patents
5. 2 out of 832,812 
Other
 patents
where one patent can have more than one assignee

Years Active: 1979-2004

Loading Chart...
Loading Chart...
Areas of Expertise:
Optically Pure Amlodipine
S(-) Lomefloxacin
Bupropion Treatments
R(-) Albuterol
Central Nervous Disorders
Gastro-Esophageal Reflux Disease
Bronchodilation Methods
Hypertension Treatments
Sleep Disorders
Infection Treatments
Cognitive Disorders
Analgesic Methods
50 patents (USPTO):Explore Patents
1. 6753338 - Methods for treating hypertension, angina, and congestive heart failure using of optically pure (-) amlodipine (2004-06-22),
2. 6534508 - Methods and compositions for treating infection using optically pure (S)-lomefloxacin (2003-03-18),
3. 6451860 - Methods for treating depression and other disorders using optically pure (−)-bupropion (2002-09-17),
4. 6451826 - Optically pure (−) amlodipine compositions (2002-09-17),
5. 6448275 - Methods for treating hypertension and angina using salts of optically pure (−) amplodipine (2002-09-10),
6. 6436936 - Methods and compositions for treating disorders, using optically pure (+) zopiclone (2002-08-20),
7. 6369113 - Method for treating depression using optically pure (−)-bupropion (2002-04-09),
8. 6337339 - Methods and compositions for treating infection using optically pure (S)-lomefloxacin (2002-01-08),
9. 6291490 - Methods and compositions for treating conditions caused by excessive calcium influx in cells using optically pure (-) amlodipine (2001-09-18),
10. 6277887 - Methods for treating Parkinson's disease using optically pure (−)-bupropion (2001-08-21),
11. 6274595 - Compositions for treating infection using optically pure (S)-lomefloxacin (2001-08-14),
12. 6110973 - Methods for treating obesity and weight gain using optically pure (2000-08-29),
13. 6083993 - Method for treating bronchospasm using optically pure R(-) albuterol (2000-07-04),
14. 6075024 - Methods for treating infection using optically pure (S)-lomefloxacin (2000-06-13),
15. 6069154 - Methods for treating gastro-esophageal reflux disease using optically (2000-05-30),

Title: The Innovative Journey of James W Young

Introduction: James W Young, a distinguished inventor based in Palo Alto, CA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: James W Young holds several patents in various technological domains, including artificial intelligence, renewable energy, and biotechnology.

Career Highlights: With a career spanning over two decades, James W Young has worked with renowned tech companies, leading research institutions, and universities to develop cutting-edge solutions that have revolutionized the industry.

Collaborations: Throughout his career, James W Young has collaborated with top scientists, engineers, and researchers to bring his visionary ideas to life. His collaborative efforts have resulted in the successful implementation of numerous groundbreaking projects.

Conclusion: James W Young's relentless passion for innovation and his commitment to pushing the boundaries of technology continue to inspire the next generation of inventors and entrepreneurs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…